Evidence map›Paper›PMID 32524309›Full record

ArticleInternational journal of hematology2020

Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Hideho Henzan, Ken Takase, Tomohiko Kamimura, Yasuo Mori, Goichi Yoshimoto, Hiromi Iwasaki, Koji Nagafuji, Ryosuke Ogawa, Tetsuya Eto, Naoyuki Uchida and 7 more

Erratum issuedAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Hideho HenzanDepartment of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Ken TakaseDepartment of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
Tomohiko KamimuraDepartment of Hematology, Harasanshin Hospital, Fukuoka, Japan.
Yasuo MoriDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Goichi YoshimotoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Hiromi IwasakiDepartment of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
Koji NagafujiDepartment of Hematology, Kurume University Hospital, Kurume, Japan.
Ryosuke OgawaDepartment of Hematology, Japan Community Health Care Organization Kyushu Hospital, Kita-Kyushu, Japan.
Tetsuya EtoDepartment of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Naoyuki UchidaDepartment of Hematology, Toranomon Hospital, Tokyo, Japan.
Tomoaki FujisakiDepartment of Hematology, Matsuyama Red Cross Hospital, Ehime, Japan.
Koji KatoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Mariko MinamiDepartment of Hematology, National Kyushu Medical Center, Fukuoka, Japan.
Yoshikane KikushigeDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Koichi AkashiDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Toshihiro MiyamotoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. toshmiya@intmed1.med.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0002-6533-1594
Fukuoka Blood & Marrow Transplantation Group (FBMTG)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We stratified patients with newly diagnosed acute promyelocytic leukemia (APL) according to a white blood cell (WBC) count of ≥ 3 × 10

Indexed as

Consolidation ChemotherapyAdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCytarabineFemaleForecastingHumansIdarubicinLeukemia, Promyelocytic, AcuteMaleMiddle AgedNeoplasm, ResidualPrognosisProspective StudiesCytarabineIdarubicinTretinoinAPLATRAMRDPML–RARAStratification

Identifiers

PMID32524309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.